Pharming Group N.V (PHAR) Operating Margin: 2020-2025
Historic Operating Margin for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 92.73%.
- Pharming Group N.V's Operating Margin rose 8724.00% to 92.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 39.73%, marking a year-over-year increase of 5043.00%. This contributed to the annual value of -2.90% for FY2024, which is 70.00% down from last year.
- Pharming Group N.V's Operating Margin amounted to 92.73% in Q3 2025, which was up 123.62% from -392.67% recorded in Q2 2025.
- Pharming Group N.V's 5-year Operating Margin high stood at 92.73% for Q3 2025, and its period low was -392.67% during Q2 2025.
- Moreover, its 3-year median value for Operating Margin was -6.96% (2023), whereas its average is -38.61%.
- Over the last 5 years, Pharming Group N.V's Operating Margin had its largest YoY gain of 8,724bps in 2025, and its largest YoY loss of 36,645bps in 2025.
- Quarterly analysis of 5 years shows Pharming Group N.V's Operating Margin stood at 6.82% in 2021, then slumped by 2,545bps to -18.63% in 2022, then spiked by 1,995bps to 1.32% in 2023, then spiked by 592bps to 7.23% in 2024, then skyrocketed by 8,724bps to 92.73% in 2025.
- Its Operating Margin was 92.73% in Q3 2025, compared to -392.67% in Q2 2025 and 7.23% in Q4 2024.